In T-ALL, approximately 20–30% of patients harbor mutations in STAT3 or other components of the JAK-STAT pathway, which are associated with poor prognosis and increased disease aggressiveness16,23. Here, SOAT1 is linked to acute lymphoblastic leukemia.